Pavel, talk to us about the background, what you did, and what you found.

Uh, with regard to the backgrounds, know that obesity is very often in patients with atrial fibrillation.

And if you look at the patient population in large randomized trials such as CABANA, EAST, TOP, and all of them, the, the median BMI was thirty.

It means half of the patients were obese.

And, uh, the clinical question that we try to answer is our study was whether the treatment of obesity in combination with antiarrhythmics, uh, is as effective as catheter ablation.

Because in the past, it's known that catheter ablation is superior to antiarrhythmics.

It was proven in a lot of trials, and the, the results of all the trials were similar.

And what did you find?